Abstract
The optimal intensity of myeloablation associated with a reduced-toxicity conditioning (RTC) regimen in order to decrease the relapse rate without increasing non-relapse mortality (NRM), is not well established yet. This retrospective analysis was done on 30 patients with hematological malignancies. The aim was to assess the safety of a RTC regimen based on the busulfan at a dose of 100 mg/m(2)/d intravenously for 4 d, fludarabine at a dose of 30 mg/m(2)/d for 5 d, and anti-thymoglobulins at a dose of 2.5 mg/kg/d for 2 d. The cumulative incidences of grade 2-4 acute graft-versus-host disease (GVHD) and all grades chronic GVHD were 37% and 42%, respectively. Median 1-year overall survival and disease-free survival were 66% and 50%, respectively. At 1 year, the cumulative incidence of relapse/disease progression was 33%. NRM was 3% and 17% at day 100 and 1 year, respectively. This RTC conditioning regimen can lead to a long-term disease control. Moreover, it appears to be safe with a low NRM rate among high-risk patients.
References
Apr 17, 1975·The New England Journal of Medicine·E ThomasC D Buckner
Dec 10, 1999·Pediatric Transplantation·R ChamplinS Giralt
May 23, 2001·Blood·P A McSweeneyR F Storb
Oct 11, 2002·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·J A RussellB S Andersson
Aug 22, 2003·Leukemia·M MohtyD Blaise
Apr 10, 2004·Blood·Marcos de LimaBorje S Andersson
Mar 8, 2005·Bone Marrow Transplantation·K MamloukE D Agura
Nov 25, 2005·Leukemia·A ShimoniA Nagler
May 10, 2007·Haematologica·Didier BlaiseMohamad Mohty
Aug 29, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mohamed L SorrorRainer Storb
Sep 18, 2007·Blood·Mohamed L SorrorRainer Storb
Jan 25, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Michelle GeddesJames A Russell
Feb 12, 2008·Bone Marrow Transplantation·S ChunduriD Rondelli
Aug 30, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Christopher N BredesonDouglas A Stewart
Oct 20, 2009·Experimental Hematology·Thomas PrébetMohamad Mohty
Jul 6, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Shlomo AlmogArnon Nagler
Feb 23, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Gheath AlatrashBorje S Andersson
Jun 20, 2012·Blood·Philippe ArmandHaesook T Kim
Jul 28, 2012·Stem Cell Reviews and Reports·S Abdul Wahid Fadilah, Md Pazil Aqilah
Apr 16, 2013·International Journal of Hematology·S Fadilah Abdul Wahid
Jul 5, 2013·Leukemia & Lymphoma·Colombe SaillardDidier Blaise
Aug 28, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arnon NaglerMohamad Mohty
Jan 28, 2014·Bone Marrow Transplantation·Y InamotoUNKNOWN Chronic GVHD Consortium
Aug 3, 2014·Haematologica·Claire OudinDidier Blaise
Oct 7, 2014·Cancer·Mohamad MohtyPatrice Chevallier
Nov 27, 2014·Haematologica·Didier BlaiseMohamad Mohty
May 25, 2015·Leukemia Research·Mohamed A Kharfan-DabajaMohamad Mohty